AMGN Latest Press Releases

-- May 29, 2026 --

AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE PRNewswire 4:01 PM

-- May 27, 2026 --

Ember LifeSciences announces new strategic investments boosting Series A to $27M PRNewswire 9:00 AM

-- May 19, 2026 --

AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH PRNewswire 4:05 PM

-- May 13, 2026 --

CNS Drug Delivery Technologies Are Reshaping Alzheimer's and Biodefense Research Globe Newswire 8:30 AM

-- May 11, 2026 --

The Next Generation of the GLP-1 Revolution Is Already Underway Globe Newswire 8:30 AM

-- May 7, 2026 --

AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE PRNewswire 4:01 PM

-- May 4, 2026 --

AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR PRNewswire 9:00 AM

-- April 30, 2026 --

/C O R R E C T I O N -- Amgen/ PRNewswire 7:03 PM

AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS PRNewswire 4:01 PM

-- April 24, 2026 --

AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS PRNewswire 4:01 PM

-- April 22, 2026 --

AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER PRNewswire 4:00 PM

-- April 6, 2026 --

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE PRNewswire 9:00 AM

-- April 1, 2026 --

Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy Business Wire 7:30 AM

-- March 28, 2026 --

REPATHA CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS PRNewswire 4:46 PM

-- March 5, 2026 --

AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE PRNewswire 4:01 PM

-- March 4, 2026 --

AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND PRNewswire 4:01 PM

-- March 3, 2026 --

Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight PRNewswire 5:31 PM

-- February 24, 2026 --

AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE PRNewswire 4:01 PM

-- February 16, 2026 --

Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight PRNewswire 5:31 PM

-- February 13, 2026 --

AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT PRNewswire 4:01 PM

-- February 3, 2026 --

AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS PRNewswire 4:01 PM

-- January 28, 2026 --

AMGEN ANNOUNCES WEBCAST OF 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS PRNewswire 4:01 PM

-- January 20, 2026 --

Nonprofit Health Services Organization Files Lawsuit Against Fortune 500 Pharmaceutical Company Over Prescription Drug Access Business Wire 11:34 AM

-- January 7, 2026 --

AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PRNewswire 4:01 PM

-- January 6, 2026 --

Dark Blue Therapeutics acquired by Amgen for up to $840 million PRNewswire 9:29 AM

AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE PRNewswire 9:01 AM